Item 7.01 Regulation FD Disclosure.

As previously reported in a Current Report on Form 8-K, Medicus Sciences Acquisition Corp. (the "Company") and Anteris Technologies Ltd ("Anteris") had recently commenced preliminary negotiations of a non-binding letter of intent in contemplation of a possible business combination transaction. As of this time, discussions between the Company and Anteris regarding such a possible transaction have ceased.

The information set forth above under this Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

© Edgar Online, source Glimpses